Frank Misselwitz;Dagmar Kubitza;Son-Mi Park;Klaus Wehling
发明人:
Frank Misselwitz,Dagmar Kubitza,Son-Mi Park,Klaus Wehling
申请号：
US11883218
公开号：
US09539218B2
申请日:
2006.01.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
